Vice Presisdent, Clinical Development - Rheumatology
COMPANY BACKGROUND& CULTURE Caring for the world, one person at a time, inspires and unites Johnson & Johnson. J&J embraces research and science - bringing innovative ideas, products and services to advance health and well-being. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. J&J has more than 250 companies located in 60 countries around the world. At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing, and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found. We are Janssen. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it.
Responsibilities:
This position works with the Head of Clinical Development (CD) and Head, Early Development (ED), to refine the vision, mission and strategic objectives of drug development. As a member of the Development Leadership Team, contributes to Immunology Development functional organization by managing the talent strategy, operational excellence and efficiency, and drive key innovation initiatives. The VP Clinical Development, Rheumatology is accountable for the design, implementation and reporting of all Rheumatology Late-stage Phase II and III clinical trials development in Janssen's Immunology portfolio. Candidates should have the ability to adapt their therapy area knowledge and expertise to lead and advise on immuno-inflammatory indications beyond rheumatology based on the needs of the portfolio. The successful candidate will have exceptional clinical development, functional-leadership and communications skills as well as a high degree of curiosity, innovation, entrepreneurship and a keen sense of patient unmet need. Responsibilities will include:
membership in the Immunology Therapeutic Area (TA) strategy and governance bodies, accountability for program reviews in the broader Janssen R&D structure, and overall strategy and execution for all Late-stage Rheumatology clinical development programs through product licensing. This role also has substantial responsible for defining Late Stage Development approaches for licensing/Business Development activities. Lead a team of physicians who design, implement and report all late-stage phase II and III Immunology clinical trials. Overall accountability for delivery of regulatory submissions, including oversight of the preparation of clinical portions of agency licensing applications and other regulatory submissions. Collaborate with Disease Area Strongholds (DASs), Pathway Strongholds (PASs), Discovery, Clinical Pharmacology, Medical Affairs and Commercial, and Business Development to deliver all Gastroenterology late stage development matters and identify external opportunities and platforms required for next generation Immunology products. Deliver innovative, fit-for-purpose and transformational development strategies that address high unmet needs for all Rheumatology assets in late phase clinical development. This includes next-generation combination regimens to achieve transformative levels of efficacy. Develop and maintain a strong external network including credible relationships with scientific leaders, key clinical opinion leaders, and regulatory officials as needed to advance the Immunology portfolio. Qualifications EDUCATION AND EXPERIENCE Education:
MD, or MD/PhD is ideal. Immunology or Rheumatology are preferred areas of expertise.
Experience:
At least 15 years of relevant experience in drug development or equivalent. Required Knowledge and skills:
Outstanding visionary, strategic, communication and entrepreneurial skills Strong capacity to work, collaborate, communicate, influence, and lead in a cross-functional matrix environment, delivering Immunology TA strategies with a one-team, one-portfolio mindset Strong passion to drive programs into diverse indications, based on scientific rationale and unmet medical needs Candidates should possess significant experience in clinical application of approaches to the treatment of immune diseases and a strong passion to drive programs into diverse indications, based on scientific rationale and unmet medical needs Exceptional communication skills and leadership experience in drug discovery and/or early development to communicate goals and deliverables to senior management and governance committees through J&J
Salary Range:
$250K -- $500K+
Minimum Qualification
Life SciencesEstimated Salary: $20 to $28 per hour based on qualifications.
Responsibilities:
This position works with the Head of Clinical Development (CD) and Head, Early Development (ED), to refine the vision, mission and strategic objectives of drug development. As a member of the Development Leadership Team, contributes to Immunology Development functional organization by managing the talent strategy, operational excellence and efficiency, and drive key innovation initiatives. The VP Clinical Development, Rheumatology is accountable for the design, implementation and reporting of all Rheumatology Late-stage Phase II and III clinical trials development in Janssen's Immunology portfolio. Candidates should have the ability to adapt their therapy area knowledge and expertise to lead and advise on immuno-inflammatory indications beyond rheumatology based on the needs of the portfolio. The successful candidate will have exceptional clinical development, functional-leadership and communications skills as well as a high degree of curiosity, innovation, entrepreneurship and a keen sense of patient unmet need. Responsibilities will include:
membership in the Immunology Therapeutic Area (TA) strategy and governance bodies, accountability for program reviews in the broader Janssen R&D structure, and overall strategy and execution for all Late-stage Rheumatology clinical development programs through product licensing. This role also has substantial responsible for defining Late Stage Development approaches for licensing/Business Development activities. Lead a team of physicians who design, implement and report all late-stage phase II and III Immunology clinical trials. Overall accountability for delivery of regulatory submissions, including oversight of the preparation of clinical portions of agency licensing applications and other regulatory submissions. Collaborate with Disease Area Strongholds (DASs), Pathway Strongholds (PASs), Discovery, Clinical Pharmacology, Medical Affairs and Commercial, and Business Development to deliver all Gastroenterology late stage development matters and identify external opportunities and platforms required for next generation Immunology products. Deliver innovative, fit-for-purpose and transformational development strategies that address high unmet needs for all Rheumatology assets in late phase clinical development. This includes next-generation combination regimens to achieve transformative levels of efficacy. Develop and maintain a strong external network including credible relationships with scientific leaders, key clinical opinion leaders, and regulatory officials as needed to advance the Immunology portfolio. Qualifications EDUCATION AND EXPERIENCE Education:
MD, or MD/PhD is ideal. Immunology or Rheumatology are preferred areas of expertise.
Experience:
At least 15 years of relevant experience in drug development or equivalent. Required Knowledge and skills:
Outstanding visionary, strategic, communication and entrepreneurial skills Strong capacity to work, collaborate, communicate, influence, and lead in a cross-functional matrix environment, delivering Immunology TA strategies with a one-team, one-portfolio mindset Strong passion to drive programs into diverse indications, based on scientific rationale and unmet medical needs Candidates should possess significant experience in clinical application of approaches to the treatment of immune diseases and a strong passion to drive programs into diverse indications, based on scientific rationale and unmet medical needs Exceptional communication skills and leadership experience in drug discovery and/or early development to communicate goals and deliverables to senior management and governance committees through J&J
Salary Range:
$250K -- $500K+
Minimum Qualification
Life SciencesEstimated Salary: $20 to $28 per hour based on qualifications.
|
|
 | |
